125 related articles for article (PubMed ID: 21822181)
21. Pleural fluid lactate as a point-of-care adjunct diagnostic aid to distinguish tuberculous and complicated parapneumonic pleural effusions during initial thoracentesis: Potential use in a tuberculosis endemic setting.
Kho SS; Chan SK; Yong MC; Cheah HM; Lee YG; Tie ST
Respir Investig; 2020 Sep; 58(5):367-375. PubMed ID: 32107195
[TBL] [Abstract][Full Text] [Related]
22. Measurement of lactate in pleural fluid rapidly identify infection and guide therapy.
Johansson N; Andersson Ydsten K; Backman-Johansson C; Vondracek M; Hedlund J
Infect Dis (Lond); 2023 Jun; 55(6):396-404. PubMed ID: 37021765
[TBL] [Abstract][Full Text] [Related]
23. A novel biomarker for pleural effusion diagnosis: Interleukin-36γ in pleural fluid.
Guo L; Zhang Q; Lv C; Ma X; Song X; Huang J; Chen W; Li C; Ding Q
J Clin Lab Anal; 2023 Jan; 37(1):e24799. PubMed ID: 36478612
[TBL] [Abstract][Full Text] [Related]
24. Development and Validation of the COMPLES Score for Differentiating Between Tuberculous Effusions with Low Pleural pH or Glucose and Complicated Parapneumonic Effusions.
Corral-Gudino L; García-Zamalloa A; Prada-González C; Bielsa S; Alexis D; Taboada-Gómez J; Dos-Santos-Gallego PR; Alonso-Fernández MA; Porcel JM
Lung; 2016 Oct; 194(5):847-54. PubMed ID: 27401009
[TBL] [Abstract][Full Text] [Related]
25. Biomarkers of infection for the differential diagnosis of pleural effusions.
Porcel JM; Vives M; Cao G; Bielsa S; Ruiz-González A; Martínez-Iribarren A; Esquerda A
Eur Respir J; 2009 Dec; 34(6):1383-9. PubMed ID: 19541708
[TBL] [Abstract][Full Text] [Related]
26. Pleural fluid IL-8 as an inflammatory mediator for discriminating transudates and exudates.
Zaki SM; Ashour L
Egypt J Immunol; 2007; 14(2):83-92. PubMed ID: 20306660
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic Value of C-Reactive Protein in Discrimination between Uncomplicated and Complicated Parapneumonic Effusion.
Kogan Y; Sabo E; Odeh M
Diagnostics (Basel); 2020 Oct; 10(10):. PubMed ID: 33076437
[TBL] [Abstract][Full Text] [Related]
28. The Role of Serum Coagulation Factors in the Differential Diagnosis of Patients with Pneumonia and Parapneumonic Effusion.
Marinkovic SP; Topuzovska IK; Milenkovic Z; Kaeva B
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2016 Nov; 37(2-3):81-88. PubMed ID: 27883327
[TBL] [Abstract][Full Text] [Related]
29. Pleural fluid tests to identify complicated parapneumonic effusions.
Porcel JM
Curr Opin Pulm Med; 2010 Jul; 16(4):357-61. PubMed ID: 20224408
[TBL] [Abstract][Full Text] [Related]
30. Pleural fluid cell-free DNA in parapneumonic pleural effusion.
Santotoribio JD; Cabrera-Alarcón JL; Batalha-Caetano P; Macher HC; Guerrero JM
Clin Biochem; 2015 Oct; 48(15):1003-5. PubMed ID: 26234638
[TBL] [Abstract][Full Text] [Related]
31. Matrix metalloproteinase levels in the differentiation of parapneumonic pleural effusions.
Oikonomidi S; Kostikas K; Kalomenidis I; Tsilioni I; Daenas C; Gourgoulianis KI; Kiropoulos TS
Respiration; 2010; 80(4):285-91. PubMed ID: 20453486
[TBL] [Abstract][Full Text] [Related]
32. Pleural fluid chemical analysis in parapneumonic effusions. A meta-analysis.
Heffner JE; Brown LK; Barbieri C; DeLeo JM
Am J Respir Crit Care Med; 1995 Jun; 151(6):1700-8. PubMed ID: 7767510
[TBL] [Abstract][Full Text] [Related]
33. Diagnostically significant variations in pleural fluid pH in loculated parapneumonic effusions.
Maskell NA; Gleeson FV; Darby M; Davies RJ
Chest; 2004 Dec; 126(6):2022-4. PubMed ID: 15596709
[TBL] [Abstract][Full Text] [Related]
34. Proinflammatory and antiinflammatory cytokine levels in complicated and noncomplicated parapneumonic pleural effusions.
Marchi E; Vargas FS; Acencio MM; Sigrist RMS; Biscaro MDA; Antonangelo L; Teixeira LR; Light RW
Chest; 2012 Jan; 141(1):183-189. PubMed ID: 21680642
[TBL] [Abstract][Full Text] [Related]
35. IL-8 in pleural effusion.
Ceyhan BB; Ozgün S; Celikel T; Yalçin M; Koç M
Respir Med; 1996 Apr; 90(4):215-21. PubMed ID: 8736655
[TBL] [Abstract][Full Text] [Related]
36. The differential diagnostic values of cytokine levels in pleural effusions.
Akarsu S; Kurt AN; Dogan Y; Yilmaz E; Godekmerdan A; Aygun AD
Mediators Inflamm; 2005 Feb; 2005(1):2-8. PubMed ID: 15770060
[TBL] [Abstract][Full Text] [Related]
37. Combined serum biomarkers in the noninvasive diagnosis of complicated parapneumonic effusions and empyema.
Wu KA; Wu CC; Liu YC; Hsueh PC; Chin CY; Wang CL; Chu CM; Shih LJ; Yang CY
BMC Pulm Med; 2019 Jun; 19(1):108. PubMed ID: 31215423
[TBL] [Abstract][Full Text] [Related]
38. Parapneumonic effusions and empyema.
Light RW
Clin Chest Med; 1985 Mar; 6(1):55-62. PubMed ID: 3847302
[TBL] [Abstract][Full Text] [Related]
39. Hyaluronic acid levels are increased in complicated parapneumonic pleural effusions.
Zaga T; Makris D; Tsilioni I; Kiropoulos T; Oikonomidi S; Damianos A; Gourgoulianis KI
Monaldi Arch Chest Dis; 2011 Sep; 75(3):167-71. PubMed ID: 22428219
[TBL] [Abstract][Full Text] [Related]
40. Clinical, Laboratory and Radiographic Features of Patients with Pneumonia and Parapneumonic Effusions.
Petrusevska-Marinkovic S; Kondova-Topuzovska I; Milenkovic Z; Kondov G; Anastasovska A
Open Access Maced J Med Sci; 2016 Sep; 4(3):428-434. PubMed ID: 27703568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
